title: Scar Management in the Pediatric and Adolescent Populations.
abstract: For most children and adolescents who have developed symptomatic scars, cosmetic concerns are only a portion of the motivation that drives them and their caregivers to obtain treatment. In addition to the potential for cosmetic disfigurement, scars may be associated with a number of physical comorbidities including hypertrichosis, dyshidrosis, tenderness/pain, pruritus, dysesthesias, and functional impairments such as contractures, all of which may be compounded by psychosocial factors. Although a plethora of options for treating scars exists, specific management guidelines for the pediatric and adolescent populations do not, and evidence must be extrapolated from adult studies. New modalities such as the scar team approach, autologous fat transfer, and ablative fractional laser resurfacing suggest a promising future for children who suffer symptomatically from their scars. In this state-of-the-art review, we summarize cutting-edge scar treatment strategies as they relate to the pediatric and adolescent populations.
authors.affiliation: Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, California; akrakowski@rchsd.org.
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Krakowski
authors.affiliation: Department of Dermatology, SUNY Downstate Medical Center, Brooklyn, New York;
authors.forename: Christine R
authors.initials: CR
authors.lastname: Totri
authors.affiliation: Department of Plastic Surgery, Shriner's Hospital for Children, Boston, Massachusetts; and.
authors.forename: Matthias B
authors.initials: MB
authors.lastname: Donelan
authors.affiliation: Department of Dermatology, Naval Medical Center, San Diego, California.
authors.forename: Peter R
authors.initials: PR
authors.lastname: Shumaker
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D002648:Child; D002921:Cicatrix / Q000150:complications / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D003131:Combined Modality Therapy; D062109:Dermatologic Surgical Procedures; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D015552:Injections, Intralesional; D054025:Lasers, Dye / Q000627:therapeutic use; D054020:Lasers, Gas / Q000627:therapeutic use; D050151:Subcutaneous Fat / Q000637:transplantation; D014182:Transplantation, Autologous
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D005472:Fluorouracil